BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-356@pharmaconomics
DTSTAMP:20260707T034240Z
DTSTART;VALUE=DATE:20260318
DTEND;VALUE=DATE:20260319
SUMMARY:PTGX Approval — ICOTYDE
DESCRIPTION:A final FDA approval decision on ICOTYDE for moderate-to-severe plaque psoriasis is expected Mar 18\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1377121/000110465926055629/tm2613550d1_ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/356
URL:https://www.pharmaconomics.com/e/356
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PTGX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR